Comprehensive Analysis of Somatic Mutations in Driver Genes of Resected Pancreatic Ductal Adenocarcinoma Reveals KRAS G12D and Mutant TP53 Combination as an Independent Predictor of Clinical Outcome
Sami Shoucair, Joseph R. Habib, Ning Pu, Benedict Kinny‐Köster, A. Floortje van Ooston, Ammar A. Javed, Kelly J. Lafaro, Jin He, Christopher L. Wolfgang, Jun Yu
Topics & Concepts
MedicineKRASCDKN2AInternal medicineOncologyCohortSurgical oncologyProportional hazards modelPancreatic ductal adenocarcinomaPancreatic cancerRetrospective cohort studyCancerAdenocarcinomaColorectal cancerPancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsCholangiocarcinoma and Gallbladder Cancer Studies